Gene, Cell and Tissue

Published by: Kowsar

The Catechol-Methyltransferase rs4680 G>A Polymorphism is Associated with Uterine Leiomyoma Susceptibility

Mina Heydari 1 , Saeid Ghorbian 1 , * and Manizheh Sayyah Melli 2
Authors Information
1 Department of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran
2 Department of Obstetrics and Gynecology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • Gene, Cell and Tissue: January 31, 2019, 6 (1); e86258
  • Published Online: January 30, 2019
  • Article Type: Research Article
  • Received: November 10, 2018
  • Revised: January 26, 2019
  • Accepted: January 27, 2019
  • DOI: 10.5812/gct.86258

To Cite: Heydari M, Ghorbian S, Sayyah Melli M . The Catechol-Methyltransferase rs4680 G>A Polymorphism is Associated with Uterine Leiomyoma Susceptibility, Gene Cell Tissue. 2019 ; 6(1):e86258. doi: 10.5812/gct.86258.

Abstract
Copyright © 2019, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Virchow R. Ueber makroglossie und pathologische neubildung quergestreifter muskelfasern. Archiv für pathologische anatomie und physiologie und für klinische medicin. 1854;7(1):126-38. German. doi: 10.1007/bf01936233.
  • 2. Ali M, Chaudhry ZT, Al-Hendy A. Successes and failures of uterine leiomyoma drug discovery. Expert Opin Drug Discov. 2018;13(2):169-77. doi: 10.1080/17460441.2018.1417381. [PubMed: 29254389].
  • 3. Francis JH, Kleinerman RA, Seddon JM, Abramson DH. Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol. 2012;124(2):254-9. doi: 10.1016/j.ygyno.2011.10.019. [PubMed: 22027510]. [PubMed Central: PMC3264733].
  • 4. Tuncal A, Aydin HH, Askar N, Ozkaya AB, Ergenoglu AM, Yeniel AO, et al. Increased expression of electron transport chain genes in uterine leiomyoma. Ann Clin Lab Sci. 2014;44(4):466-8. [PubMed: 25361934].
  • 5. Wang F, Chen J, Wang L, Ma Y, Mayinuer N. CYP1A1 genetic polymorphisms and uterine leiomyoma risk: A meta-analysis. Int J Clin Exp Med. 2015;8(3):3590-4. [PubMed: 26064254]. [PubMed Central: PMC4443088].
  • 6. Feng Y, Zhao X, Zhou C, Yang L, Liu Y, Bian C, et al. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM). Gene. 2013;529(2):296-9. doi: 10.1016/j.gene.2013.07.019. [PubMed: 23939469].
  • 7. Inoue S, Mizushima T, Miyamoto H. Role of the androgen receptor in urothelial cancer. Mol Cell Endocrinol. 2018;465:73-81. doi: 10.1016/j.mce.2017.06.021. [PubMed: 28652170].
  • 8. Taghizade Mortezaee F, Hashemzadeh Chaleshtori M, Kheiri S, Farrokhi E, Shariati L, Tabatabaiefar MA, et al. Interleukin-1 B gene polymorphisms in Iranian patients with uterine fibroid, a case- control study. Biosci Biot Res Asia. 2015;12(1):341-5. doi: 10.13005/bbra/1671.
  • 9. Mostafavi SS, Ebrahimi A, Sadat SM, Davari Tanha F, Aghasadeghi MR, Bahramali G, et al. Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population. J Obstet Gynaecol Res. 2016;42(4):434-9. doi: 10.1111/jog.12924. [PubMed: 26785830].
  • 10. Kotula-Balak M, Milon A, Pawlicki P, Opydo-Chanek M, Pacwa A, Lesniak K, et al. Insights into the role of estrogen-related receptors alpha, beta and gamma in tumor Leydig cells. Tissue Cell. 2018;52:78-91. doi: 10.1016/j.tice.2018.04.003. [PubMed: 29857832].
  • 11. Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. Genomics. 1992;12(4):822-5. doi: 10.1016/0888-7543(92)90316-K. [PubMed: 1572656].
  • 12. Ates O, Demirturk F, Toprak M, Sezer S. Polymorphism of catechol-o-methyltransferase and uterine leiomyoma. Mol Cell Biochem. 2013;375(1-2):179-83. doi: 10.1007/s11010-012-1540-3. [PubMed: 23238870].
  • 13. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34(13):4202-10. doi: 10.1021/bi00013a008. [PubMed: 7703232].
  • 14. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet. 1996;67(5):468-72. doi: 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G. [PubMed: 8886163].
  • 15. Zhu G, Lipsky RH, Xu K, Ali S, Hyde T, Kleinman J, et al. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5' nuclease assay. Psychopharmacology (Berl). 2004;177(1-2):178-84. doi: 10.1007/s00213-004-1938-z. [PubMed: 15290009].
  • 16. Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: Associations with differing cognitive operations. Biol Psychiatry. 2005;58(11):901-7. doi: 10.1016/j.biopsych.2005.05.010. [PubMed: 16043133].
  • 17. Diamond A, Briand L, Fossella J, Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry. 2004;161(1):125-32. doi: 10.1176/appi.ajp.161.1.125. [PubMed: 14702260].
  • 18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi: 10.1093/nar/16.3.1215. [PubMed: 3344216]. [PubMed Central: PMC334765].
  • 19. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 1997;57(24):5493-7. [PubMed: 9407957].
  • 20. Ando T, Kato H, Furui T, Morishige KI, Goshima S, Matsuo M. Uterine smooth muscle tumours with hyperintense area on T1 weighted images: Differentiation between leiomyosarcomas and leiomyomas. Br J Radiol. 2018;91(1084):20170767. doi: 10.1259/bjr.20170767. [PubMed: 29308922]. [PubMed Central: PMC5966007].
  • 21. Dzhemlikhanova LK, Efimova OA, Osinovskaya NS, Parfenyev SE, Niauri DA, Sultanov IY, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for MED12 exon 2 mutations. J Clin Pathol. 2017;70(3):233-6. doi: 10.1136/jclinpath-2016-203976. [PubMed: 27491313].
  • 22. Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015;21(5):593-615. doi: 10.1093/humupd/dmv030. [PubMed: 26141720]. [PubMed Central: PMC4533663].
  • 23. Pietrowski D, Thewes R, Sator M, Denschlag D, Keck C, Tempfer C. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene. Am J Reprod Immunol. 2009;62(2):112-7. doi: 10.1111/j.1600-0897.2009.00718.x. [PubMed: 19614627].
  • 24. Hsieh YY, Chang CC, Tsai CH, Lin CC, Tsai FJ. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril. 2007;87(4):886-95. doi: 10.1016/j.fertnstert.2006.07.1541. [PubMed: 17222831].
  • 25. Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K, et al. Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol. 2008;35(1):35-40. [PubMed: 18390078].
  • 26. Denschlag D, Bentz EK, Hefler L, Pietrowski D, Zeillinger R, Tempfer C, et al. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril. 2006;85(2):462-7. doi: 10.1016/j.fertnstert.2005.07.1308. [PubMed: 16595228].
  • 27. Gooden KM, Schroeder JC, North KE, Gammon MD, Hartmann KE, Taylor J, et al. Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci. 2007;14(2):117-20. doi: 10.1177/1933719106298687. [PubMed: 17636223].
  • 28. de Oliveira E, de Aquino Castro R, Gomes MT, da Silva ID, Baracat EC, de Lima GR, et al. The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids. Maturitas. 2008;60(3-4):235-8. doi: 10.1016/j.maturitas.2008.07.001. [PubMed: 18752908].
  • 29. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006;13(2):136-44. doi: 10.1016/j.jsgi.2005.10.007. [PubMed: 16443508].
  • 30. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res. 1999;59(19):4870-5. [PubMed: 10519398].
  • 31. Zhao XM, Xie MQ, Yang DZ, Wang LA, Li SJ, Zhuang YY, et al. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer]. Zhonghua Fu Chan Ke Za Zhi. 2007;42(2):116-9. Chinese. [PubMed: 17442187].
  • 32. Juo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum Reprod. 2006;21(6):1498-502. doi: 10.1093/humrep/del033. [PubMed: 16527884].
  • 33. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis. 1998;19(1):1-27. doi: 10.1093/carcin/19.1.1. [PubMed: 9472688].
  • 34. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A. 1995;92(20):9220-4. doi: 10.1073/pnas.92.20.9220. [PubMed: 7568105]. [PubMed Central: PMC40956].
  • 35. Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet. 2008;25(8):389-94. doi: 10.1007/s10815-008-9246-x. [PubMed: 18763031]. [PubMed Central: PMC2582125].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments